The Burette is handled exclusively by MLA. It was decided by The Board that this was the better method to open Analytica as a Medical Device Coy. If you peruse the annual accounts you will find that Analytica is making a modest royalty from this. More importantly it appears Royaltys are growing. Frankly it is a Medical Device that is more likely to impress Doctors than the greater populace therefore wont achieve the breakthrough that other Devices or Drugs that gain higher media attention.
Thats not saying that the Burette cannot make a tremendous impact in itself if it were to become popular as the Burettes it seeks to replace. That Market is huge and runs into $Billions in annual sales. However the Device best suits an emergency or field type issuance which limits its capacity to some degree. Why? Because of the self cleaning feature. Most IV's are purely a 100-150ml bag of saline with Drugs included via a secondary collar. There is no need for a self cleaning feature in those. But in an emergent or endemic situation you would find that you would be using an AutoStartBurette because it is the only Burette capable of delivering.
Thats its niche. It is the only Burette capable of delivering. If Hospitals or Medicos were properly financed by Govts I think you would find a cache of these Devices being used constantly worldwide. Thats the basic problem that the Burette faces in getting Hospitals and Emergent Services to "hold" this Device because "luckily" we havent had to draw upon this Resource. This Device was formulated at a time when Avian flu etc were becoming pendamic. Today its Ebola.
But Hospices and Emergency Services are constantly stretched with normal saline bags today. The danger lies in cutting medical services to the point it creates a pandemic in itself. Here enters the Burette in giving Govts breathing space without losing capacity to deal with Daily/Emergent situations.
It would only take one Emergent Worldwide situation for this Device to be the most purchased and used product eclipsing any Medical Device in the history of all Medical Devices.
Thats worth the investment in Analytica alone.
The PeriCoach now adds to a niche of Devices that Dr Monsour focuses on delivering a better health system to us all.
T1
ALT Price at posting:
2.8¢ Sentiment: Hold Disclosure: Held
